Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
Barbara Mora, Hematologist at I.R.C.C.S. Ospedale Maggiore Policlinico, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Happy to share that our collaborative work on the characterization of a recently discovered intronic variant of the erythropoietin gene as a cause of congenital erythrocytosis has been published on the American Journal of Hematology!”
Title: Characterization of a Newly Discovered Non‐Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis
Authors: Barbara Mora, Valentina Bellani, Daniela Pietra, Elena Tagliaferri, Daniele Cattaneo, Oscar Borsani, Alessandra Iurlo, Elisa Fermo, Paola Bianchi, Elisa Rumi, Francesco Passamonti
Read the Full Article on American Journal of Hematology
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction
-
Jul 9, 2026, 08:46Jordan Agay: Folate Deficiency in Patients Receiving PARP Inhibitors
-
Jul 9, 2026, 08:29Laura Katz: Is Human Lactoferrin Better Than Bovine Lactoferrin?
-
Jul 9, 2026, 08:17Anziya Sabeer: AI-Driven Non-Invasive Anemia Detection
-
Jul 9, 2026, 07:37Variable Mechanisms of ADAMTS13 Inhibition by Autoantibodies in iTTP – JTH